Longitudinal metabolic study of red blood cells from patients undergoing gender-affirming testosterone therapy

Blood Adv. 2023 Aug 22;7(16):4269-4277. doi: 10.1182/bloodadvances.2022008061.

Authors

Micaela Kalani Roy¹, Rebecca Burgoyne Wilkerson¹, Keisha Alexander¹, Natalie J Nokoff^{2

3}, Melanie Cree-Green^{2

3}, Angelo D'Alessandro¹

Affiliations

¹ Department of Biochemistry & Molecular Genetics, Graduate School, University of Colorado, Anschutz Medical Campus, Aurora, CO.
² Division of Pediatric Endocrinology, Department of Pediatrics, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO.
³ Ludeman Family Center for Women's Health Research, University of Colorado, Anschutz Medical Campus, Aurora, CO.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Erythrocytes*
Humans
Longitudinal Studies
Testosterone* / therapeutic use

Substances

Testosterone

Grants and funding